Fiarresga Antonio, De Sousa Lídia, Martins José Dioco, Ramos Ruben, Paramés Filipa, Freitas Isabel, Oliveira José Alberto, Trigo Conceiçãao, Agapito Ana, Ferreira Rui Cruz, Pinto Fátima
Serviço de Cardiologia do Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisboa, Portugal.
Rev Port Cardiol. 2010 May;29(5):767-80.
Atrial septal defects (ASD) are among the most common congenital anomalies and account for 10% of congenital heart disease in the pediatric age-group and 30% in adults. Closure is indicated when there is evidence of hemodynamic significance or after a paradoxical embolic event. Ten years ago, percutaneous closure became the treatment of choice in our center for all patients with a clear indication and favorable anatomy. In this paper we report the experience of this first decade.
To assess the short- and long-term results of our ten-year experience with percutaneous closure of atrial septal defects.
We studied retrospectively all patients with ASD treated with a percutaneous approach between November 1998 and December 2008. The pediatric age-group consisted of patients younger than 19 years old. Demographic data, clinical indications, minor and major complication rates, success rate and long-term outcome were assessed.
In the first ten years of experience 510 patients, of whom 166 were in the pediatric group, were treated in our center by a team of adult and pediatric cardiologists. The overall success rate of the procedure was 98% (97.5% in ASD and 99.5% in patent foramen ovale (PFO). The minor complication rate was 3% (3.4% in ASD and 2% in PFO). The most frequent complication was supraventricular tachycardia. The major complication rate was 1.2% (0.6% in ASD and 2% in PFO). Two patients developed cardiac tamponade due to hemopericardium that was resolved by pericardiocentesis, without need for surgery. One patient had an arterial pseudoaneurysm corrected by vascular surgery. There was no device embolization and no need for urgent surgery in this population. During follow-up two patients had recurrence of ischemic stroke, one had a transient ischemic attack and another had a hemorrhagic stroke. Mortality was 0.6% (0.6% in ASD and 0.5% in PFO). There were no in-hospital deaths. During follow-up there were two deaths, both in the adult group.
In this population the success rate was high and most of the complications were minor. The results of this collaboration between adult and pediatric cardiologists in the first ten years of activity confirm the safety and efficacy of percutaneous closure of septal defects, when there is careful patient selection and a standardized technique.
房间隔缺损(ASD)是最常见的先天性畸形之一,在儿童年龄组中占先天性心脏病的10%,在成人中占30%。当有血流动力学意义的证据或发生反常栓塞事件后,需进行封堵。十年前,经皮封堵术在我们中心成为所有有明确适应证且解剖结构适宜患者的首选治疗方法。在本文中,我们报告这第一个十年的经验。
评估我们十年间经皮封堵房间隔缺损的短期和长期结果。
我们回顾性研究了1998年11月至2008年12月间所有采用经皮方法治疗的ASD患者。儿童年龄组包括19岁以下的患者。评估人口统计学数据、临床适应证、轻微和严重并发症发生率、成功率及长期结果。
在最初十年的经验中,我们中心由成人和儿童心脏病专家团队治疗了510例患者,其中166例在儿童组。该手术的总体成功率为98%(ASD为97.5%,卵圆孔未闭(PFO)为99.5%)。轻微并发症发生率为3%(ASD为3.4%,PFO为2%)。最常见的并发症是室上性心动过速。严重并发症发生率为1.2%(ASD为0.6%,PFO为2%)。两名患者因心包积血发生心脏压塞,通过心包穿刺得以解决,无需手术。一名患者的动脉假性动脉瘤通过血管手术矫正。该人群中未发生器械栓塞,也无需紧急手术。随访期间,两名患者发生缺血性中风复发;一名患者发生短暂性脑缺血发作;另一名患者发生出血性中风。死亡率为0.6%(ASD为0.6%,PFO为0.5%)。无住院死亡病例。随访期间有两例死亡,均在成人组。
在该人群中成功率较高,且大多数并发症为轻微并发症。成人和儿童心脏病专家在活动的第一个十年间的合作结果证实,在仔细选择患者并采用标准化技术时,经皮封堵间隔缺损具有安全性和有效性。